Dementia

Latest content

Biomarkers are biological indicators that can be measured to assess the presence, severity, or progress of a disease. In the context of Alzheimer’s disease, biomarkers can include proteins and genetic markers to reflect underlying disease processes. ©shutter2u, ©123RF

Editorial ArticleDrug Discovery & Development

Simoa Technology aims to transform future Alzheimer's disease detection and treatment

Learn how biomarkers can be used to transform drug approval and patient management in neurodegenerative medicine

13 Nov 2024

Editorial ArticleDrug Discovery & Development

Simoa Technology aims to transform future Alzheimer's disease detection and treatment

13 Nov 2024

Industry NewsDrug Discovery & Development

Allyx Therapeutics announces first Parkinson’s disease patient treated with ALX-001

10 Sept 2024

Industry NewsClinical Diagnostics

Beckman Coulter and Fujirebio expand partnership to develop patient-friendly, blood-based neurodegenerative disease diagnostics

13 Mar 2024

Webinars

Examining T-cell dynamics in the human brain and its borders using cell sorting, genomics and inter-cell communication mapping tools

Available on-demand

Watch on-demand

Editorial Articles

Biomarkers are biological indicators that can be measured to assess the presence, severity, or progress of a disease. In the context of Alzheimer’s disease, biomarkers can include proteins and genetic markers to reflect underlying disease processes. ©shutter2u, ©123RF

Editorial Article

Simoa Technology aims to transform future Alzheimer's disease detection and treatment

13 Nov 2024

Editorial Article

Husband & Wife Duo Combating Dementia Through Neurological Research

2 Apr 2017

Editorial Article

Understanding the Inflammatory Response to Stroke in the Human Brain through Mouse Models

1 Feb 2017

Resources

Product Brochures

Differential Dementia Diagnostics

23 Feb 2018

News

Industry News

Prestigious £1.6M MRC Career Development Award given to develop dementia diagnostic tool

3 Jul 2025

Industry News

Allyx Therapeutics announces first Parkinson’s disease patient treated with ALX-001

10 Sept 2024

Industry News

Beckman Coulter and Fujirebio expand partnership to develop patient-friendly, blood-based neurodegenerative disease diagnostics

13 Mar 2024

Industry News

Beckman Coulter and Fujirebio bolster Alzheimer’s disease therapeutics

16 Jul 2023

Dementia